Resonance Health Ltd (AU:RHT) has released an update.
Resonance Health Limited reports a remarkable financial turnaround with revenues doubling to $8.59 million and a profit of $169,303 for the year ended June 30, 2024, a significant recovery from the previous year’s loss of $780,361. The company also completed the acquisition of TrialsWest Pty Ltd, contributing $97,869 to the group’s profits. No dividends were paid during this period, and the financial statements received an unmodified audit opinion.
For further insights into AU:RHT stock, check out TipRanks’ Stock Analysis page.
